Catheter
AssigneeAngeLase, Inc.
InventorsJeffrey M. Isner, Richard Clarke
Life of this patent
Estimating the term…
Abstract
A technique for percutaneous treatment of idiopathic hypertrophic subaortic stenosis (IHSS) and hypertrophic cardiomyopathy (HCM). IHSS and HCM are diseases of the heart in which the septum of the left ventricle thickens resulting in reduced ventricular performance. Current treatments involve drug therapy or a medical intervention called an interoperative myotomy/myectomy using the Morrow procedure. The present invention uses laser energy delivered via fiber optics placed percutaneously to irradiate the thickened septum to reduce tissue volume of the septum and enhance left ventricular function.
Claims2
A process for treating hypertophic cardiomyopathy in idiopathic hypertrophic subaortic stenosis in a patient comprising the steps of:
- a. percutaneously entering a blood vessel of said patient with a distal end of a catheter assembly, said catheter assembly comprising a lumen through which runs an optical fiber and a single fixation wire;
- b. advancing said distal end of said catheter assembly until positioned adjacent myocardial tissue in the heart of said patient;
- c. fixing aid distal end of said catheter assembly adjacent said myocardial tissue by urging a sigmoidal bend of said catheter assembly into contact with the inner walls of said heart and by advancing said fixation wire in said catheter assembly distally so that said fixation wire penetrates tissue of said heart;
- d. advancing a distal end of said optical fiber within said catheter assembly;
- e. coupling a proximal end of said optical fiber to an output of a medical laser;
- and,
- f. irradiating said myocardial tissue with laser energy transferred from said medical laser to said distal end of said optical fiber.
Dependencies are inferred from the claim text.